OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
227
Results
Show all
Save search
Copy query
Show results for
Unknown
(188)
Transcriptomics
(20)
Genomics
(16)
Proteomics
(3)
Organisms
Homo sapiens
(26)
Mus musculus
(6)
Rattus norvegicus
(2)
Propionibacterium freudenreichii subsp. freudenreichii
(1)
Organisms
Zea mays subsp. mays
(2)
Helianthus annuus
(1)
Medicago sativa
(1)
Repository
biostudies-arrayexpress
(20)
EGA
(12)
ENA
(4)
pride
(3)
Tissue
Abdominal adipose tissue
(1)
Articular cartilage
(1)
Articular chondrocyte
(1)
Cell culture
(1)
Hepatocyte
(1)
Liver
(1)
Mesenchymal stem cell of adipose
(1)
Disease
Cholangiocarcinoma
(1)
Knee osteoarthritis
(1)
Technology Type
Mass Spectrometry
(3)
Unknown
(1)
Bottom-up proteomics
(1)
Data-dependent acquisition
(1)
Gel-based experiment
(1)
Shotgun proteomics
(1)
Instrument Platform
Illumina NovaSeq 6000
(1)
Publication Date
2012
(13)
2024
(2)
2016
(2)
2015
(2)
2013
(1)
2011
(1)
2022
(1)
2018
(1)
First Public Date
2021
(3)
2022
(1)
Study type
Transcription profiling by array
(15)
Comparative genomic hybridization by array
(2)
RNA-seq of non coding RNA from single cells
(1)
Genotyping by array
(1)
Transcription profiling by RT-PCR
(1)
Release Date
2024
(24)
2023
(22)
2021
(22)
2025
(21)
2022
(21)
2012
(15)
2020
(15)
2018
(10)
2015
(8)
2013
(8)
2011
(8)
2016
(7)
2017
(7)
2019
(5)
2014
(4)
2010
(4)
2009
(3)
2026
(2)
2008
(1)
2002
(1)
Lab affiliation
Head of Proteomics
(1)
Hepatology Program, CIMA, University of Navarra. Avda. Pio XII, n55. 31008 Pamplona, Spain.
(1)
Inserm U1183 Institut de Médecine Régénératrice et Biothérapies (IRMB Equipe 1 France
(1)
Previous
page
1 / 23
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
23
Next
page
Sort
by:
Relevance
Page size
10
Association of cognitive function with increased risk of cancer death and all-cause mortality: Longitudinal analysis, systematic review, and meta-analysis of prospective observational studies.
Not available
S-EPMC8741047
|
biostudies-literature
Cite
Randomised controlled trial of exercise to prevent shoulder problems in women undergoing breast cancer treatment: study protocol for the prevention of shoulder problems trial (UK PROSPER).
Not available
S-EPMC5875650
|
biostudies-literature
Cite
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER.
Not available
S-EPMC10394474
|
biostudies-literature
Cite
Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997.
Not available
S-EPMC5947152
|
biostudies-literature
Cite
PeRsOnaliSed care Planning for oldER people with frailty (PROSPER): protocol for a randomised controlled trial.
Not available
S-EPMC10759371
|
biostudies-literature
Cite
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Not available
S-EPMC3053238
|
biostudies-literature
Cite
Effects of PROSPER on the influence potential of prosocial versus antisocial youth in adolescent friendship networks.
Not available
S-EPMC3725467
|
biostudies-literature
Cite
Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation.
Not available
S-EPMC8579424
|
biostudies-literature
Cite
Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance.
Not available
S-EPMC3834161
|
biostudies-literature
Cite
Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial.
Not available
S-EPMC12721655
|
biostudies-literature
Cite
Previous
page
1 / 23
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
23
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets